| 2025-11-21 |
详情>>
内部人交易：
Jerman Michael Allen等共交易3笔
|
| 2025-11-14 |
详情>>
股本变动：
变动后总股本223.18万股
|
| 2025-11-14 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.84美元,归母净利润-328.3万美元,同比去年增长16.61%
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-1.3美元,归母净利润-212.4万美元,同比去年增长24.41%
|
| 2025-06-17 |
复牌提示：
2025-06-16 12:08:03 停牌，复牌日期 2025-06-16 12:13:03
|
| 2025-05-21 |
股东大会：
将于2025-07-03召开股东大会
会议内容 ▼▲
- 1.To elect each of the four nominees for director named in this proxy statement (the “proxy statement”) to hold office until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified or, if sooner, until his or her earlier death, resignation or removal (“Proposal 1”);
2.To ratify the selection of Cherry Bekaert LLC as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025 by the audit committee (the “audit committee”) of the Board (“Proposal 2”);
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement (“Proposal 3”);
4.To approve the amendment and restatement of the Company’s third amended and restated certificate of incorporation, as amended (our “Charter”), in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the Board, effect a reverse stock split with respect to the Company’s issued and outstanding common stock, par value $0.001 per share, including stock held by the Company as treasury shares, at a reverse stock split ratio of 1-for-5 to 1-for-20, inclusive (“Proposal 4” or the “Reverse Stock Split Proposal”);
5.To approve an amendment to the Company’s Charter, in substantially the form attached to the proxy statement as Annex B, to, at the discretion of the Board, increase the number of shares of common stock authorized for issuance thereunder from 5,000,000 shares to 50,000,000 shares (“Proposal 5” or the “Authorized Stock Increase Proposal”);
6.To approve an amendment to the Company’s 2020 Equity Incentive Plan to increase the number of shares that the Company may issue under the Plan from 130,745 shares to 1,130,745 shares (“Proposal 6” or the “EIP Amendment Proposal”);
7.To approve a proposal to adjourn the Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal 4 and Proposal 5 (“Proposal 7” or the “Adjournment Proposal”).
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.67美元,归母净利润-107.3万美元,同比去年增长36.21%
|
| 2025-03-31 |
详情>>
业绩披露：
2024年年报每股收益-2.92美元,归母净利润-467.9万美元,同比去年增长86.68%
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-2.46美元,归母净利润-393.7万美元,同比去年增长85.58%
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-1.75美元,归母净利润-281万美元,同比去年增长85.07%
|
| 2024-07-18 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.11美元,归母净利润-168.2万美元,同比去年增长83.26%
|
| 2024-04-26 |
股东大会：
将于2024-06-06召开股东大会
会议内容 ▼▲
- 1.To elect each of the five nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2025 annual meeting of stockholders and until his or her successor is duly elected and qualified or, if sooner, until his or her earlier death, resignation or removal (“Proposal 1”);
2.To ratify the selection of RSM US LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024 by the audit committee (the “audit committee”) of the board of directors of the Company (the “Board”) (“Proposal 2”);
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement (“Proposal 3”);
4.To approve the amendment and restatement of the Company’s second amended and restated certificate of incorporation, as amended (our “Charter”), in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the Board, effect a reverse stock split with respect to the Company’s issued and outstanding common stock, par value $0.001 per share, including stock held by the Company as treasury shares, at a reverse stock split ratio of 1-for-5 to 1-for-15, inclusive (“Proposal 4”);
5.To approve an amendment to the Company’s Charter, in substantially the form attached to the proxy statement as Annex B, to, at the discretion of the Board, increase the number of shares of common stock authorized for issuance thereunder from 34,666,667 shares to 50,000,000 shares (“Proposal 5”);
6.To approve a proposal to adjourn the Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal 4 and Proposal 5 (“Proposal 6”);
7.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2024-04-01 |
详情>>
业绩披露：
2023年年报每股收益-2.2美元,归母净利润-3514万美元,同比去年增长6.86%
|
| 2024-02-01 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.11美元,归母净利润-2729.7万美元,同比去年增长4.46%
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-0.08美元,归母净利润-1882.1万美元,同比去年增长4.56%
|
| 2023-05-10 |
财报披露：
美东时间 2023-05-10 盘前发布财报
|
| 2023-04-25 |
股东大会：
将于2023-06-06召开股东大会
会议内容 ▼▲
- 1.To elect each of the seven nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2024 annual meeting of stockholders and until his or her successor is duly elected and qualified or, if sooner, until his or her earlier death, resignation or removal (“Proposal 1”);
2.To ratify the selection of RSM US LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023 by the audit committee (the “audit committee”) of the board of directors of the Company (the “Board”) (“Proposal 2”);
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement (“Proposal 3”);
4.To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers (“Proposal 4”);
5.To approve the amendment and restatement of the Company’s amended and restated certificate of incorporation, as amended (our “Charter”), in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the Board, effect a reverse stock split with respect to the Company’s issued and outstanding common stock, par value $0.001 per share, including stock held by the Company as treasury shares, at a reverse stock split ratio of 1-for-5 to 1-for-15, inclusive (“Proposal 5”);
6.To approve an amendment to the Company’s Charter, in substantially the form attached to the proxy statement as Annex B, to, at the discretion of the Board, increase the number of shares of common stock authorized for issuance thereunder from 420,000,000 shares to 520,000,000 shares (“Proposal 6”);
7.To approve a proposal to adjourn the Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal 5 and Proposal 6 (“Proposal 7”);
8.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2022-04-27 |
股东大会：
将于2022-06-13召开股东大会
会议内容 ▼▲
- 1.To elect each of the seven nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2023 annual meeting of stockholders and until his or her successor is duly elected and qualified or, if sooner, until his or her earlier death, resignation or removal;
2.To ratify the selection of RSM US LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022 by the audit committee (the “audit committee”) of the board of directors of the Company (the “Board”);
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement;
4.To approve the amendment and restatement of the Company’s amended and restated certificate of incorporation, as amended (our “Charter”), in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the Board, effect a reverse stock split with respect to the Company’s issued and outstanding common stock, par value $0.001 per share, including stock held by the Company as treasury shares, at a reverse stock split ratio of 1-for-5 to 1-for-15, inclusive;
5.To approve an amendment to the Company’s Charter, in substantially the form attached to the proxy statement as Annex B, to, at the discretion of our Board, increase the number of shares of common stock authorized for issuance thereunder from 350,000,000 shares to 420,000,000 shares;
6.To approve a proposal to adjourn the Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal 4 and Proposal 5;
7.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2021-04-07 |
股东大会：
将于2021-05-19召开股东大会
会议内容 ▼▲
- 1.To elect the seven nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2022 annual meeting of stockholders and until their successors are duly elected and qualified (Proposal 1);
2.To ratify the selection by the audit committee of the board of directors of RSM US LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021 (Proposal 2);
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement (Proposal 3);
4.To approve an amendment to the Company’s amended and restated certificate of incorporation to increase the authorized number of shares of common stock from 250,000,000 shares to 350,000,000 shares (Proposal 4);
5.To transact any other business as may properly come before the annual meeting or any adjournments thereof.
|
| 2020-05-18 |
股东大会：
将于2020-06-29召开股东大会
会议内容 ▼▲
- 1.To elect the seven (7) nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2021 annual meeting of stockholders and until their successors are duly elected and qualified (Proposal 1);
2.To ratify the selection by the audit committee of the board of directors of RSM US LLP as the Company’s independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020 (Proposal 2);
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement (Proposal 3);
4.To approve the Company’s 2020 Equity Incentive Plan (the “2020 Plan”) (Proposal 4);
5.To approve an amendment to the Company’s amended and restated certificate of incorporation (the “charter”) to increase the authorized number of shares of common stock from 250,000,000 shares to 445,000,000 shares (Proposal 5);
6.To transact any other business as may properly come before the annual meeting or any adjournments thereof.
|
| 2019-04-29 |
股东大会：
将于2019-06-13召开股东大会
会议内容 ▼▲
- 1.To elect the board’s five nominees for director named in the accompanying proxy statement to hold office until the 2020 annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the selection by the audit committee of the board of directors of RSM US LLP as the Company’s independent registered public accounting firm of the Company for its fiscal year ending December 31, 2019;
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement;
4.To transact any other business as may properly come before the meeting or any adjournments thereof.
|
| 2018-08-08 |
股东大会：
将于2018-09-18召开股东大会
会议内容 ▼▲
- 1.To elect the board’s five nominees for director named in the accompanying proxy statement to hold office until the 2019 annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the selection by the audit committee of the board of directors of RSM US LLP as the Company’s independent registered public accounting firm of the Company for its fiscal year ending December 31, 2018;
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement;
4.To approve an amendment to the Company’s 2012 Equity Incentive Plan, as amended, to increase the aggregate number of shares of common stock authorized for issuance thereunder from 9,000,000 shares to 14,000,000 shares;
5.To transact any other business as may properly come before the meeting or any adjournments thereof.
|
| 2017-04-28 |
股东大会：
将于2017-06-14召开股东大会
会议内容 ▼▲
- 1.To elect six directors;
2.To ratify the appointment of RSM US LLP as our independent registered public accounting firm for 2017;
3.To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement;
4.To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers;
5.To transact any other business as may properly come before the meeting or any adjournments thereof.
|
| 2016-04-28 |
股东大会：
将于2016-06-15召开股东大会
会议内容 ▼▲
- 1.To elect six directors;
2.To ratify the appointment of RSM US LLP (formerly McGladrey LLP) as our independent registered public accounting firm for 2016;
3.To approve, on an advisory basis, the compensation of our named executive officers as identified in the proxy statement for the annual meeting; 4.To transact any other business as may properly come before the meeting or any adjournments thereof.
|